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Uncoupling of Grb2 from the Met Receptor In Vivo
Reveals Complex Roles in Muscle Development
Flavio Maina,*† Franca Casagranda,* genes in the mouse causes embryonal lethality between
E12.5 and E15.5, owing to abnormal development of theEnrica Audero,† Antonio Simeone,‡
placenta (Schmidt et al., 1995; Uehara et al., 1995). InPaolo M. Comoglio,†§ Ru¨diger Klein,*
homozygous mutant embryos, the liver is reduced inand Carola Ponzetto†
size and shows extensive loss of parenchymal cells*European Molecular Biology Laboratory
(Schmidt et al., 1995). Furthermore, consistent with theMeyerhofstrasse 1
scattering activity of HGF, Met-deficient embryos lack69117 Heidelberg
muscles of the limbs, diaphragm, and tip of the tongue,Federal Republic of Germany
all deriving from migratory precursors (Bladt et al.,1995).†Department of Biomedical Sciences and Oncology
Considerable progress has been made in understand-University of Torino
ing the mechanism of Met signaling in cultured cells.10126 Torino
We have previously shown that the biological activity ofItaly
the receptor depends on the presence of two phospho-‡International Institute of Genetics and Biophysics
tyrosines (Y1349VHVNATY1356VNV) in the carboxy-terminalvia G. Marconi 12
tail, which act as multifunctional docking sites for SH2-80125 Napoli
containing effectors and activate an array of transduc-Italy
tional pathways (Ponzetto et al., 1994). The Y1356VNV§ Institute for Cancer Research
motif, in particular, binds Grb2 (Songyang et al., 1993)10060 Candiolo (Torino)
and links the receptor with Ras. Mutation of Y1356 aloneItaly
interferes heavily with all Met-mediated events, whereas
mutation of Y1349 has only a limited effect on transforma-
tion and no effect on motility. Mutation of both tyrosinesSummary
completely abrogates Met function (Ponzetto et al.,
1994; Zhu et al., 1994; Fixman et al., 1995; Weidner etHepatocyte growth factor (HGF) and its receptor, the
al., 1995; Ponzetto et al., 1996).Met tyrosine kinase, are determinants of placenta,
We and others have aimed at determining the rolesliver, and muscle development. Here, we show that
of specific downstream signaling pathways in the bio-Met function in vivo requires signaling via two carboxy-
logical activities of HGF. By interfering with Ras (Ridleyterminal tyrosines. Mutation of both residues in the
et al, 1995; Hartmann et al., 1994) and by using specificmouse genome caused embryonal death, with pla-
PI 3-kinase inhibitors (Royal and Park, 1995), we and
centa, liver, and limb muscle defects, mimicking the
others have shown these two pathways to be necessary
phenotype of met null mutants. In contrast, disrupting
to mediate scattering. Our approach to assess the con-the consensus for Grb2 binding allowed development
tribution of the Ras pathway in the HGF response wasto proceed to term without affecting placenta and liver
to construct a Met mutant in which Grb2 binding is
but caused a striking reduction in limb muscle coupled
specifically abrogated while all other effectors can still
to a generalized deficit of secondary fibers. These data
bind. This was done by mutating the asparagine in posi-
show that the requirements for Met signaling vary de-
tion 12 of Y1356 into histidine (YVNV→YVHV). By express-pending on the tissue and reveal a novel role for HGF/ ing this mutant in cultured cells, we have shown that a
Met in late myogenesis. direct link with Grb2 is required to promote transforma-
tion, but it is not essential to trigger the scatter response
Introduction (Ponzetto et al., 1996).
In this work, we aimed at interfering with coupling of
Hepatocyte growth factor (HGF), also known as scatter the Met receptor to its effectors in vivo. To obtain a
factor (SF), is a pleiotropic growth factor which, besides severe loss-of-function phenotype, we inserted into
promoting cell survival and proliferation, has the ability the met locus a double Y→F mutation of Y1349 and Y1356
to dissociateepithelial sheetsand to stimulate cell motil- (Y1349VHVNATY1356VNV→F1349VHVNATF1356 VNV, MetD).
ity (Gherardi and Stoker, 1991; Weidner et al., 1991). Conversely, to obtain an hypomorphic mutant, we intro-
HGF also induces kidney epithelial cells to form duced the N→H mutation described above (Y1356VN
branching ducts incollagen gels (Montesano et al.,1991) V→Y1356VHV, MetGrb2). We reasoned that this partial loss-
and triggers intrinsic morphogenic programs in a variety of-function mutation would probably allow us to single
of epithelial cell lines (Brinkmann et al., 1995). In vivo, out some of the developmental functions of HGF on the
HGF is involved in organ regeneration (Matsumoto and basis of their different requirements for the signaling
Nakamura, 1993), angiogenesis (Bussolino et al., 1992), pathway or pathways activated by the receptor through
and tumor invasiveness (Weidner et al., 1990; Giordano a direct link with Grb2. The MetD mutation was lethal
et al., 1993). All these events are mediated by a single and mimicked the phenotype of the met null mutants,
receptor, the Met tyrosine kinase (Naldini et al., 1991; thereby confirming the importance of the multifunctional
Bottaro et al., 1991). During embryogenesis, met is ex- docking sites in vivo. The MetGrb2 mutation spared pla-
pressed in the epithelial component of various organs, centa and liver and allowed the fetus to develop to term
while hgf is expressed in the adjacent mesenchyme but resulted in a generalized muscle phenotype, reveal-
ing a novel function for HGF/Met in late myogenesis.(Sonnenberg et al., 1993). Inactivation of the hgf or met
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Figure 1. Knock-In of Point Mutations in the
met Locus
(A) Diagram of the targeting vector, wild-type
and mutant alleles, and resulting chimeric
protein. The human MET cDNA fragment
fused in-frame with the third exon of the ge-
nomic clone, codes for the transmembrane
and cytoplasmic domain of the Met receptor.
After homologous recombination, the neo
cassette remains within the mutant allele. N
indicates cleavage sites for NdeI. The 59
probe identifies a 16 kb NdeI DNA fragment
in the wild-type allele and a 12 kb NdeI DNA
fragment in the mutant allele (see [B]). Nota-
tions “1” and “2” indicate the location of the
oligonucleotides used for PCR screening of
the double-selected ES cells. The chimeric
protein can specifically be recognized by
anti-human Met antibodies raised against the
unique carboxy-terminal peptide. Asterisk in-
dicates the carboxy-terminal SH2 multifunc-
tional docking sites (amino acids are num-
bered according to the human c-MET DNA
sequence deposited at EMBL/GenBank with
accession number X54559). MetWT: chimeric
protein with wild-type multifunctional tyro-
sines. MetGrb2: chimeric protein with disrupted
Grb2 binding site. MetD: chimeric protein with
mutated multifunctional tyrosines.
(B) Southern blots of NdeI digests of genomic
DNA isolated from double-selected ES cell
clones (lanes 1–11), transfected with the
metWT, metD, and metGrb2 constructs. Lane 2:
ES cell clone in which both alleles were tar-
geted. Lanes R: R1 ES cell control DNA. The
probe used (position shown in [A]) identifies
a 16 kb NdeI DNA fragment in the wild-type
allele and a 12 kb NdeI fragment in the recom-
binant allele.
(C) Northern blot of total RNA isolated from
liver of wild-type (1/1), metWT/1 (1/2) and
metWT/WT (2/2) mice. The higher 8.8 kb band
is the endogenous transcript, and the 7.2 kb
band is the recombinant transcript. The dif-
ference in size is due to the fact that in the
recombinant allele, the 39 untranslated region
is substituted by the 1.2 kb b-globin 39 un-
translated region and polyadenylation site.
The probe used was a mouse met cDNA frag-
ment located in the extracellular domain (see
Experimental Procedures) common to both
alleles.
(D) Immunoprecipitation and Western blot of extracts of E15.5 homozygous and control (1/1) embryos. Left: the antibody used for immunopre-
cipitation and Western blotting was specific for the human Met protein. Right: the antibody used for immunoprecipitation and Western blotting
was specific for the mouse Met protein.
Results of a murine extracellular domain fused to a human trans-
membrane and cytoplasmic domain. The hybrid recep-
tor can thus interact optimally with the endogenous li-Replacement of the Wild-Type Met Receptor
with Signaling Mutants gand (Rong et al., 1992). Should the fusion exon be
excised by an alternative splicing event, the coding se-Point mutations were introduced into the multifunctional
docking sites of the Met receptor (Y1349VHVNATY1356VNV) quence would be out of frame and result in a functional
knock-out. A set of three different constructs was made.using the “knock-in” approach (Hanks et al., 1995). To
construct the targeting vector, we inserted a human A wild-type human MET cDNA served to produce a con-
trol mouse (metWT). A cDNA carrying a double Y→F sub-MET cDNA fragment (coding for the transmembrane and
cytoplasmic domain of the receptor) in-frame as a cas- stitution (Y1349VHVNATY1356VNV→F1349VHVNATF1356VNV)
was used to create a severe signaling mutant (metD).sette in a mouse genomic clone (Figure 1A). The cDNA
was followed by 1.2 kb of b-globin 39-untranslated re- A cDNA carrying a N→H substitution that selectively
disrupts Grb2 binding (Y1356VNV→Y1356VHV) was used togion and polyadenylation site and by the neo cassette.
The protein resulting from the targeted allele consists produce a partial loss-of-function Met mutant (metGrb2).
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protein at similar levels and do not express the endoge-Table 1. Viability of Embryos from met D/1 Heterozygous Matings
nous protein (Figure 1D). Using the same type of analy-
Number of pups % 1/1 % met D/1 % met D/D
sis, we also verified that the mutant receptor is ex-
E12.5 50 24 50 26 pressed at comparable levels in wild-type and metWT/WT
E13.5 73 23 59 15 3* mice invarious organs including liver,kidney, and spleen
E14.5 66 23 56 15 6*
(data not shown).E15.5 52 33 44 10 13*
E16.5 78 28 49 9 14*
E17.5 59 24 54 3 19* Loss of the Met Multifunctional Docking Sites
E18.5 60 30 52 0 18* Results in Embryonal Lethality and
P0 42 36 64 0 Recapitulates the Defects of met
* % of metD/D embryos partially resorbed. and hgf Null Mutants
Homozygous metWT/WT mice were obtained at the ex-
pected frequency, did not show any obvious phenotype,
and were fertile. In contrast, matings between heterozy-G418R-GancR double-selected embryonic stem (ES)
cells were screened by polymerase chain reaction (PCR) gous metD/1 mice did not produce any live homozygous
progeny. Embryos were collected and genotyped begin-and Southern blot analysis (Figure 1B). Recombinant ES
cells were microinjected into C57BL/6J blastocysts to ning at E12.5. It has been reported that at this develop-
mental stage, the met/hgf null mutants are 25% of theproduce chimeric animals. Breeding of the chimerae
with wild-type C57BL/6J animals gave the expected fre- total number of embryos (Schmidt et al., 1995; Uehara
et al., 1995; Bladt et al., 1995), and this was found toquency of heterozygous for all three constructs. Hetero-
zygous mice did not show any apparent phenotype and be true also in the case of metD/D homozygotes. The
number of live homozygous embryos started to declinewere fertile. To compare the levels of endogenous and
recombinant met transcripts, we analyzed by Northern at E13.5, was less than 10% by E16.5, and none were
found alive beyond E17.5 (Table 1). In summary, theblots RNA from liver of wild-type, heterozygous, and
homozygous animals using a probe specific for the com- timing of lethality for metD/D embryos was very similar
to that observed in the met/hgf null mutants, the onlymon mouse Met extracellular domain. Figure 1C shows
that the transcripts originating from the endogenous difference being that a few homozygous embryos sur-
vived one or two days longer. metD/D placentas and em-(8.8 kb mRNA) and mutated (7.2 kb mRNA) alleles are
expressed at comparable levels. Extracts of E15.5 ho- bryos were reduced in size with respect to wild-type and
heterozygous littermates (data not shown). The placentamozygous mutant embryos were immunoprecipitated
using anti-Met antibodies specifically recognizing either became visibly paler and smaller than controls one day
earlier (E13.5) than the embryo, indicating that this de-the carboxy-terminus of human Met or the mouse Met
protein. Western blots of these immunoprecipitates fect is likely to be the cause of embryonal lethality.
In metD/D embryos, as in met/hgf nulls, the size of theshow that all three homozygous mutant embryos
(metWT/WT, metGrb2/Grb2, metD/D) express the recombinant liver was reduced (data not shown), and the limbs, tip
Figure 2. Loss of the Met Multifunctional
Docking Sites Results in Lack of Muscles De-
riving from Migratory Myoblasts
Hematoxylin–eosin staining of sections of di-
aphragm (A–C) and myosin staining of sec-
tions of forelimbs (D–F), back (G–I), and rib
cage (J–L) of E15.5 embryos of the indicated
genotypes. In metD/D mutant embryos, dia-
phragm and forelimb muscles are absent,
while back and intercostal muscles are nor-
mal. lu, lung; d, diaphragm; li, liver; h, hom-
erus; r, rib. Magnification: 400 3 (A–C); 100 3
(D–I), 200 3 (J–L).
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Figure 3. Uncoupling Grb2 from Met Is Com-
patible with Term Development and Affects
Muscles Deriving from Migratory Precursors
(A–C) Homozygous mutant mice of the indi-
cated genotype at P0. Forelimbs of metGrb2/Grb2
mice are hyperflexed. metGrb2/D mice are born
alive, but they retain a fetal position and die
a few minutes after birth.
(D–I) Sections of the forearm of mutant mice
at P0, taken halfway between the wrist and
the elbow (D–F) and at the level of the elbow
(G–I). Hematoxylin–eosin staining shows a
graded reduction in muscle mass, progres-
sively more severe in metGrb2/Grb2 and metGrb2/D
mutants.
(J–L) Sections of the diaphragm stained with
phalloidin. u, ulna; r, radius; lu, lung; d, dia-
phragm; li, liver. Magnification: 50 3 (D–I);
400 3 (J–L).
of the tongue, and diaphragm lacked muscles entirely. birth, probably owing to respiratory failure, as they ap-
pear cyanotic at death. Occasionally, a few metGrb2/Grb2All theaffected muscles originate from migratory precur-
sors (Wachtler and Christ, 1992; Ordahl and LeDouarin, homozygous animals survived for variable lengths of
time, ranging from several days to a few months. During1992). In Figure 2, details of the diaphragm and limb
muscles are shown at E15.5. This stage was chosen to the first week of postnatal growth, these animals did
not increase in size like the metWT/WT controls, retainedmake possible a direct comparison of the metD/D pheno-
type with that of the null mutant described in Bladt et the hyperflexed phenotype in their forelimbs, and
showed a reduction in total muscle mass. Animals sur-al. (1995). Figures 2A–2C show that the diaphragm lacks
muscles in metD/D embryos. Figures 2D–2F show that viving for longer times did tend to recover (to a variable
degree) in body size, muscle mass, and strength. Tomyotubes are completely absent in the forelimbs of
metD/D embryos. Muscles of the back, rib cage, and me- obtain a loss-of-function mutantof intermediate severity
with respect to metGrb2/Grb2 and metD/D mice, we crosseddial region of the tongue (data not shown), in contrast
to migratory muscles, develop normally up to this stage the corresponding heterozygotes to generate metGrb2/D
mice. These mice were also born alive at the expected(E15.5) in metD/D embryos (see Figures 2G–2L), as in met
null embryos (Bladt et al., 1995). frequency but died within a few minutes of respiratory
failure. At birth, they retained a curled fetal position, andThese observations show that while replacement of
the endogenous Met protein with a murine–human fu- their total muscle mass was visibly reduced (Figure 3C).
The corresponding placentae appeared slightly smallersion product per se has no effect on development, loss
of both Y1349 and Y1356 produces a phenotype essentially compared with controls but were well vascularized (data
not shown).coinciding with that observed in met and hgf null mu-
tants. To understand the reason for the abnormal limb pos-
ture in metGrb2/Grb2 mice, we sectioned and stained their
forelimbs with hematoxylin–eosin. Figures 3D–3I showMutation of the Met Grb2 Binding Site Affects
Postnatal Viability and Development of Muscles sections of the forearm of metGrb2/Grb2 homozygous mu-
tants at P0, compared with those of metWT/WT controlsDeriving from Early Migratory Precursors
In contrast to the embryonal lethality of metD/D embryos, and metGrb2/D mutants. In the limbs of metGrb2/Grb2 mice,
the muscles are strikingly reduced (Figures 3E and 3H).live metGrb2/Grb2 homozygous pups were obtained at the
expected frequency. This indicates that the N→H muta- This results in the prevalence of flexors over extensors,
thereby causing the observed hyperflexed phenotypetion allows for development of a functional placenta,
which is indeed morphologically normal in these mutant (Figure 3B). The muscle reduction is more extreme in
metGrb2/D mutants (Figures 3F and 3I). A pattern ofmice (data not shown). metGrb2/Grb2 mice are easily identifi-
able at birth because of their hyperflexed forelimbs and “graded” reduction (comparable with that seen in the
forelimbs) was also found in every other muscle derivingweak hindlimbs (Figure 3B). Otherwise, they do not sig-
nificantly differ from thewild-type controls and are capa- from migratory myoblasts, such as those of the dia-
phragm (Figures 3J–3L), shoulders, hindlimbs, and tipble of moving, feeding, and reacting to external stimuli.
However, they die almost invariably several hours after of the tongue (data not shown).
Met Signaling Mutants in Development
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Figure 4. Loss of the Link with Grb2 Does Not Affect Differentiation of Embryonal Myoblasts or Their Migration out of the Somites
(A–C) Whole-mount hybridization of E11.5 embryos with a MyoD probe. Myogenic cells in the axial and neck muscles (wide arrow) are
unaffected by the Met mutations. Developing appendicular muscles (thin arrow) are reduced in metGrb2/Grb2 embryos, but they are positive for
expression of MyoD. metD/D embryos lack myogenic cells in shoulders and limbs.
(D–F) Whole-mount hybridization of E10 embryos with a met probe. Myoblast precursors in metWT/WT and metGrb2/Grb2 embryos leave the somite
and enter the limb bud, while they do not migrate out of the somite in metD/D embryos. Probes are described in Experimental Procedures.
Loss of the Link with Grb2 Does Not Affect those of the medial tongue, rib cage, and back) that do
not originate from migratory precursors and appear toDifferentiation of Embryonal Myoblasts
or Their Migration out of the Somites be normal up to E15.5 in every met mutant, including
metD/D (see Figures 2I and 2L) and met nulls (Bladt etWhen examined at high magnification, the fibers in the
appendicular muscles of the mutant mice at P0 showed al., 1995). At P0, in metGrb2/Grb2 and metGrb2/D mutants, the
medial region of the tongue was disorganized, and mus-nuclei located at the periphery, indicating that fusion had
occurred. However, the defect observed could reflect a cle fibers appeared to be loosened and dissociated from
each other (Figures 5A–5C). The same abnormal mor-delay in the program of myogenic differentiation. To test
this hypothesis, we examined, by in situ hybridization, phology was also observed in intercostal and body-wall
muscles (Figures 5D–5I) and in back muscles. A close-the expression of the differentiation factor MyoD in em-
bryos at E11.5, when MyoD mRNA is first detectable in up of back muscles (Figures 5J–5L) shows that, in addi-
tion to the “loose” structure, there is also a differencethe myogenic cells of the limb (Lyons and Bucking-
ham, 1992). MyoD was expressed at equivalent levels in the caliber and number of muscle fibers, particularly
evident in the metGrb2/D mutant.in the developing axial muscles of metWT/WT controls,
metGrb2/Grb2, and metD/D mutant mice (Figures 4A–4C). The The appearance of this phenotype in muscles that
develop normally up to mid-gestation suggested to usMyoD signal was absent in the limbs of metD/D mutants,
reflecting the absence of myogenic cells at this site. In that Met could be required tomediate an event occurring
in late myogenesis, such as the formation of secondarythe limbs of metGrb2/Grb2 embryos, fewer cells were labeled
relative to the metWT/WT control, but these few were fibers from fetal myoblasts. Secondary fibers (which be-
gin to form at E14 in the mouse) are clearly detectablestrongly MyoD-positive. These embryonic myoblasts
thus undergo differentiation according to a normal time- at E17.5, interdispersed between primary fibers, and still
distinguishable owing to the difference in their diameter.table. Myogenic precursors were then traced back at
E10, when they first leave the somite and begin entering Primary and secondary fibers were counted on sections
of intercostal muscles (double-stained for myosin andthe limb bud. In situ hybridization with the met probe
showed that in metD/D embryos, myoblast precursors fail laminin) obtained from E17.5 metWT/WT, metGrb2/Grb2, and
metGrb2/D embryos (Figures 6A–6C). The count revealedto migrate out of the somites (Figure 4F). Conversely,
in metGrb2/Grb2 embryos, myoblast precursors initiate their a reduction in secondary fibers of 28% and 57% in
metGrb2/Grb2 and metGrb2/D embryos, respectively (Table 2).migration in a way similar to that of metWT/WT controls
(Figures 4D and 4E). Fetal myoblasts lie quiescent beneath the basal lam-
ina of primary myotubes throughout the embryonal
phase of myogenesisuntil they resume proliferation, justMutation of the Grb2 Binding Site Reveals
That Met Signaling Is Required for before E14. The reduction in secondary fiber formation
observed in the mutants suggested that HGF/Met couldDevelopment of Secondary Fibers
While the most obvious anomaly in metGrb2/Grb2 mice at be involved in controlling proliferation of their precur-
sors. To label myogenic nuclei in S phase, we injectedbirth was the defective development of limb muscles,
the phenotype of the more severe metGrb2/D mutant pregnant mice twice with bromodeoxyuridine (BrdU) at
E15 and 15.5, and they were sacrificed at E17.5. Labeledseemed to indicate that not only appendicular but also
axial muscles were affected (see Figure 3C). Thus, histo- nuclei were counted on sections of intercostal muscles
obtained from E17.5 embryos (Figures 6D–6F). Inlogical analysis was extended also to muscles (such as
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Figure 5. Loss of the Link with Grb2 Affects
Development of Muscles That Do Not Origi-
nate from Migratory Precursors
Phalloidin staining of middle tongue (A–C)
and intercostal muscles (D–I) of mutant mice
at P0. The muscle structure appears to be
progressively more disorganized in metGrb2/Grb2
and metGrb2/D mutants. Fibers are diminished
in number and seem to be dissociated from
each other. Close-up of hematoxylin–eosin
staining of back muscles (J–L) shows empty
spaces between fibers and a reduction in fi-
ber caliber. ap, apical surface of the tongue;
b, body wall muscles; r, rib. Magnification:
100 3 (A–F), 200 3 (G–I), 400 3 (J–L).
metGrb2/Grb2 and metGrb2/D mutants, there was a reduction in in muscle at the appropriate time. In situ hybridization
with a met-specific probe shows that met is indeedlabeled nuclei of 33% and 52%, respectively, compared
with the metWT/WT controls (Table 2). This result indicates expressed in intercostal as well as in axial muscles of
E15.5 embryos, when fetal myoblasts are proliferatingthat a defect in the proliferation of fetal myoblasts is
likely toaccount for the observed reduction insecondary (Figure 7A). It was of interest for the interpretation of
the phenotype of the metGrb2/Grb2 mutant to verify whetherfibers.
Met and Grb2 were coexpressed in myogenic cells be-
fore fusion into myotubes. To this end, we establishedMet and Grb2 Are Coexpressed in Fetal Myoblasts
If Met is directly involved in the control of fetalmyoblasts primary cultures of fetal myoblasts, starting from mus-
cles recovered from limbs of normal embryos at E16.5proliferation, it should be possible to detect met mRNA
Figure 6. Loss of the Link with Grb2 Affects Development of Secondary Fibers
(A–C) Representative sections of intercostal muscles at E17.5 double-stained with anti-myosin (MAb MF20 and rhodamin-conjugated goat
anti-mouse) and anti-laminin (polyclonal L9393 and fluorescein-conjugated goat anti-rabbit), used to count secondary fibers (marked with
asterisks).
(D–F) BrdU-labeled nuclei in sections of intercostal muscle of E17.5 embryos. Pregnant mothers were injected 2 days earlier. Counts of labeled
nuclei were made on BrdU/laminin overlays (insert; laminin was detected using rhodamin-conjugated goat anti-rabbit sera). Only nuclei found
underneath basal laminas (arrow) were counted. Arrowheads show examples of nuclei outside fibers. Magnification: 630 3 (A–C); 400 3 (D–F).
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Table 2. Number of Primary and Secondary Fibers and BrdU-Labeled Nuclei in Intercostal Muscle of Mutant E17.5 Embryos
Number of fibers or nuclei plus or minus standard error of the mean/
0.025 mm2
met WT/WT metGrb2/Grb2 met Grb2/D
Primary fibers 90 6 4 87 6 3a 82 6 4a
Secondary fibers 71 6 2 51 6 5b 30 6 5b
BrdU-labeled nuclei 54 6 5 36 6 2b 26 6 2b
The number of fibers was calculated on serial sections (four) for each E17.5 embryo (three) of a given genotype. BrdU-labeled nuclei
located underneath the basal lamina of the fiber were counted in different fields (three) of each serial section (three) for each
E17.5 embryo (three) of a given genotype. Statistical analysis was carried out using Student’s t-test.
a Not significant compared to metWT/WT.
b P , 0.0001 compared to metWT/WT.
of development. The cell suspension was preplated on that the Met protein is easily detectable in myoblasts
(lane 2) but is no longer expressed upon differentiationuncoated dishes to remove most of the fibroblasts. My-
oblasts (which do not adhere to plastic) were plated on into myotubes (lane 3) and (as expected) is absent in
fibroblasts (lane 4). Grb2, on the other hand, is ex-collagen-coated dishes and kept in a proliferation or
differentiation medium (high or low serum) until they pressed in every cell type, and its level seems actually
to increase following treatment with low serum, both indifferentiated into twitching myotubes. Figure 7B shows
Figure 7. Met and Grb2 Are Coexpressed in
Fetal Myoblasts
(A) In situ hybridization of intercostal (left) and
back (right) muscles of E15.5 embryos with a
met-specific probe (described in Experimen-
tal Procedures). r, ribs. Magnification: 100 3.
(B) Western blots of immunoprecipitates ob-
tained from extracts (equalized for the
amount of total proteins) of primary cultures
of myogenic cells derived from E16.5 em-
bryos. Lanes 1–4: Met immunoprecipitates of
liver (lane 1), myoblasts (lane 2), myotubes
(lane 3), and fibroblasts (lane 4). Lanes 5–9:
Grb2 immunoprecipitates of C2C12 myo-
geniccells undifferentiated (lane 5) and differ-
entiated (lane 6), myoblasts (lane 7), myo-
tubes (lane 8), and fibroblasts obtained from
the preplating step (lane 9; see Experimental
Procedures).
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the myogenic cell line used as control (lanes 5–6) and its SH2 domain and links them to downstream effectors
via its SH3 domains. The most widely studied amongin the primary cultures (lanes 7–8).
the partners of Grb2 is the Ras guanine nucleotide ex-Although these results do not rule out the possibility
changer Sos. We and others have shown that uncou-that other molecules could also bind to the the Grb2
pling Met from Grb2 lowers the HGF–dependent Rasconsensus site in Met, they demonstrate that Grb2 and
response to approximately 50% of that evoked by theMet are coexpressed in fetal myoblasts and indicate
wild-type receptor (Besser et al., submitted; Fixman etthat in muscle precursor cells, Grb2 can indeed be a
al., 1996). Thus, a first conclusion drawn from our in vivodownstream effector of Met.
results is that the function of HGF in placenta and liver
can be fulfilled by a lower threshold of Met-mediated
Discussion Ras signal. In placenta and liver, HGF may protect cells
from apoptosis, rather than promoting proliferation (a
Mutating the Carboxy-Terminal Multifunctional function that is likely to require full Ras signaling).
Docking Sites Is Equivalent to Abrogating In contrast to placenta and liver, muscles deriving
the Met Receptor from migratory precursors (such as those of the limbs,
In this report, we demonstrate that interfering with Met diaphragm, and tip of the tongue) were heavily affected
receptor signaling has profound and complex effects on by the Grb2-directed mutation, indicating a requirement
embryonal development. The two multifunctional SH2 for Grb2-mediated signaling in migratory myoblasts. The
docking sites of the receptor (Y1349 and Y1356) were modi- defect was, however, attenuated with respect to the
fied by introducing a fragment of human MET cDNA metD/D and null mutants, since these muscles were re-
carrying the mutations of interest into the met locus duced rather than absent. The presence of muscles in
via homologous recombination. The control mouse the limbs of metGrb2/Grb2 mice indicates that at least some
(metWT/WT, expressing a murine–human Met chimeric pro- myoblast precursors end up reaching their final destina-
tein derived from the fusion with a wild-type human tion in the limb buds. The reduction in muscle seems
cDNA) was normal and fertile, demonstrating the validity not to be due to a delay in differentiation, since MyoD
of this approach. The severe loss-of-function mutant was found to be expressed in the limbs of the metGrb2/Grb2
(metD/D), obtained by eliminating the two docking sites mutants at the appropriate time (E11.5). On the other
through Y→F substitutions, yielded the equivalent of a hand, at E11.5 there is already a substantial reduction
null mutant. Homozygous metD/D mice died in utero with in the number of myogenic cells found in the limbs.
a similar (albeit slightly delayed) timing as met null mice This suggests that the Met mutation affects myoblast
and had the same defects in placenta, liver, and limb precursors during their migratory phase (E9.5–E10.5). In
muscles. This indicates that the two carboxy-terminal situ hybridization with the met probe at E10 (the appro-
multifunctional docking sites are essential to transduce priate time to observe the initial stages of migration)
showed that mutant myoblasts left the somites and be-the HGF signal during embryonal development. Our data
gan entering the limb bud in a manner similar to theso far do not address the specific roles of Y1349 and Y1356.
controls. This is in keeping with our observation thatIndividual mutations could be generated to establish
MDCK cells expressing the same mutant are fully com-the relative importance of these docking sites in vivo.
petent in the scatter response (Ponzetto et al., 1996).Tyrosines Y1365 and Y1001 have also been implicated in
However, to colonize the limb, myogenic cells not onlyMet signaling (Weidner et al., 1995). Mutation of the
need toactivate the specificmachinery involved in motil-carboxy-terminal Y1365 has the effect of inhibiting epithe-
ity but must also acquire the ability to survive and prolif-lial cell branching morphogenesis. Our data indicate that
erate during migration. Their survival or proliferation (orthe presence of Y1365 alone does not rescue the lethal
both) may also depend on Met-mediated signaling. Inphenotype caused by mutations in Y1349 and Y1356 and
contrast to the situation in a culture dish, in vivo HGFtherefore suggest a rather limited role for Y1365-specific
is unequally distributed, and the highest concentrationsignaling. It is possible, however, that a mutation in
of its active form may not be within reach of every cell.Y1365 alone may reveal subtle defects in vivo, which are
If the residual ability of the metGrb2/Grb2 myoblasts to signalovershadowed by the dramatic effects of the combined
through Met is borderline in terms of the requirementY1349 and Y1356 mutations. Furthermore, in vitro, mutation
for one of the functions mentioned earlier, only thoseof the juxtamembrane Y1001 results in a gain-of-function
cells in which the signal is sustained by optimal levelsphenotype (constitutively motile “fibroblastoid” epithe-
of HGF may actually be competent to reach the mostlial cells) and suppresses the loss-of-function effect of
distal destination, or to act as progenitor of the appro-mutations in Y1356 or Y1365 (Weidner et al., 1995). It would
priate number of daughter cells, or both. This couldbe interesting to verify in vivo the consequences of mu-
explain why the phenotype of the metGrb2/D mutants is intating Y1001, alone or in combination with individual car-
all cases a more severe version of that observed inboxy-terminal mutations.
metGrb2/Grb2 mice. In metGrb2/D myoblasts, only one allele
produces Met receptor with a residual ability for signal-
Mutation of the Met Grb2 Binding Site Affects ing. Thus, the number of receptors capable of residual
Development of Migratory Muscles function per cell is half that found in metGrb2/Grb2 my-
Interfering with the ability of Met to bind Grb2 by dis- oblasts, and an even higher concentration of HGF is
rupting its optimal consensus (Y1356VNV→Y1356VHV) al- required to elicit a productive response. This further
lowed development to proceed to term, sparing pla- reduces the number of cells likely to be exposed to an
centa and liver, which in these mice appear to be normal. adequate amount of the ligand. The alternative possibil-
ity that the phenotype of the metGrb2/D mutants may beThe Grb2 adaptor binds tyrosine kinase receptors with
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due to a dominant-negative effect of the product of as well as in axial muscles, at the right time and in the
right cells to play a role in the formation of secondarythe metD allele seems unlikely, given the absence of a
phenotype in met1/D heterozygotes. fibers from fetal myoblasts.
Given the importance of the Ras pathway in cell prolif-
eration, it is tempting to correlate the proliferative defect
Mutation of the Grb2 Binding Site Reveals of fetal myoblasts caused by the loss of the link with
That Met Is Required for Development Grb2 to the inability of this Met mutant to reach a full
of Secondary Fibers threshold of Ras activation. However, the SH3 domains
Surprisingly, at birth, in metGrb2/Grb2 and metGrb2/D mice not of Grb2 can also potentially couple Met to other signal-
only migratory but also nonmigratory muscles (such as ing molecules besides Sos, including Vav (Ye and Balti-
those of the back and intercostals), were reduced, al- more, 1994), c-Abl (Ren et al., 1994), dynamin (Gout et
though to a lesser extent than appendicular muscles. al., 1993), dystroglycan (Yang et al., 1995), and Gab-1
The morphology of these muscles at P0 was abnormal, (Holgado-Madruga et al., 1996). Vav and c-Abl seem to
with smaller fiber caliber and empty spaces between play a role mainly in hematopoietic cells, and dystrogly-
fibers. This was unexpected, as these muscles were can is part of thedystrophin-associated protein complex
normal up to mid-gestation in all mice, including the found in the sarcolemma of mature muscle fibers, but
more severe metD/D and null mutants (Bladt et al., 1995). it has no known function in myoblasts. On the other
Since myogenesis occurs in two waves, with secondary hand, Gab-1, a novel IRS-1–like docking protein that
muscle fibers just beginning to form in mid-gestation, associates with Grb2 following epidermal growth factor
we reasoned that a developmental defect related to the and insulin stimulation, seems to be an intriguing possi-
formation of secondary myotubes could easily have es- bility, especially if it is found tobe expressed specifically
caped detection in the more severe mutants (metD/D and in myoblasts.
null), which die at around this stage of development. In conclusion, our data indicate that the abnormal
Thus, we counted secondary versus primary fibers at development of skeletal muscle in mice expressing Met
E17.5, when the two fiber types can most easily be signaling mutants is due to the sum of an early and a
discriminated given their difference in size, and found late effect. Met is necessary, with its full potential for
that there was a 28% and 57% reduction in secondary signaling via Grb2, in embryonic myoblasts, which mi-
fibers in metGrb2/Grb2 and metGrb2/D mice, respectively. Be- grate out of the somite and colonize the limb bud to
fore fusing into secondary fibers, fetal myoblasts reenter form appendicular muscles. Our results suggest that a
the cell cycle and undergo a phase of active prolifera- direct link with Grb2 is not needed to promote the initial
tion. Bromodeoxyuridine-labeling revealed that a defect events involved in the migration of myoblasts out of
in proliferative activity of fetal myoblasts is likely to be the somites but rather to sustain their proliferation or
responsible for the reduction in secondary fibers ob- survival or both during migration. Later in embryogene-
served in the mutants. It was recently reported that HGF sis, Met is again required, in its full signaling capacity,
activates quiescent satellite cells in vitro, stimulating to enhance proliferation of fetal myoblasts from which
their precocious entry into the cell cycle (Allen et al., secondary fibers are formed.
1995). If this were true also for fetal myoblasts, it could
explain why the reduction in secondary fibers is never
more severe than 60%, as it was found to be in the two Experimental Procedures
live E17.5 metD/D embryos that we could examine. Future
Targeting Vectorstudies on primary cultures of embryonal myoblasts,
Mouse met genomic DNA clones were selected by screening a 129/fetal myoblasts, and satellite cells derived from the via-
sv l genomic library (gift of A. Reaume), using a 550 bp HindIII–SacI
ble metGrb2/Grb2 mice will serve to establish the precise DNA fragment corresponding to position 2199–2749 in the mouse
dependence of these cell types on HGF for exit from cDNA sequence (Chan et al., 1988). The recombinant phage used
to construct the targeting vector (see wild-type allele in Figure 1)quiescence, proliferation, and motility.
contained an 11 kb insert that included two exons in the Met extra-If the role of HGF/Met in late myogenesis is direct,
cellular domain (positions 2361–2581 and 2582–2727), the exon en-the met and hgf genes should be expressed in muscle
coding the transmembrane domain (2728–2881), and the first exonat the right time, before formation of secondary fibers.
in the cytoplasmic domain (2882–3021). A 1.6 kb genomic SapI–ScaI
Previous work has shown that met is expressed in axial DNA fragment was excised from the 39 end of the 11 kb clone.
muscles at E13 and E15, while it is down-regulated in The fragment contained the last 24 bp of the exon encoding the
transmembrane domain and the first exon in the cytoplasmic do-later stages (Sonnenberg et al., 1993). By in situ hybrid-
main. The SapI–ScaI fragment was first subcloned into pBluescriptization, we now show that met is indeed expressed in
SK, then shuttled into BamHI–EcoRI-restricted pPNT plasmidintercostal and axial muscles at E15.5, when fetal my-
(Tybulewicz et al., 1991) to serve as 39 homologous region (pPNT-oblasts proliferate and are on the verge of undergoing
short arm). To fuse the human MET cDNA in-frame with mouse
fusion to form secondary fibers. Using primary cultures genomic exon sequence, a BsaWI site present in the mouse met
of myogenic cells derived from the limbs of E16.5 em- coding sequence 59 to the transmembrane domain (nucleotide 2775)
was introduced in the appropriate position in the human cDNA by anbryos, we also show that Met protein is coexpressed
in vitro site-directed mutagenesis system (Promega). The mutatedwith Grb2 in myoblasts and is down-regulated in myo-
human MET cDNA was then ligated to 1.2 kb of 39-untranslatedtubes. On the other hand, hgf mRNA has been found in
region and polyadenylation site of the b-globin gene. A fragment ofintercostal muscles at E13 and E14 (Takebayashi et al.,
the human MET cDNA, beginning at the inserted BsaWI site and
1995) and is stably expressed up to E15 in the limbs including the heterologous 39untranslated region and polyadenyla-
(Sonnenberg et al., 1993). In summary, these studies tion site, was ligated downstream to a 7.2 kb SapI–EcoRI genomic
DNA fragment representing the 59 part of the original genomic clone.indicate that met and hgf are expressed in appendicular
Cell
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This fusion product (long arm) was subsequently subcloned into the 0.5% Triton X-100 [pH 7.5]). The sections were blocked with 10%
goat serum in TBSTfor 30 min and incubated for 3 hr with the primaryNotI–XhoI sites of pPNT-short arm.
antibody. The antibodies used were anti-myosin (monoclonal MF20,
provided by Dr. G. Cossu) and anti-laminin (polyclonal L-9393,Transfection of ES Cells and Blastocyst Injection
Sigma). Affinity-purified fluorescein (FITC)–conjugated goat anti-Cell culture, electroporation of R1 ES cells (Nagy et al., 1993), selec-
rabbit and rhodamin-conjugated goat anti-mouse were purchasedtion with G418 and GANCR, and blastocyst injection were essentially
from Jackson Immunoresearch Laboratories. Images were takendone as described (Klein et al., 1993).
with a Fluorescence Image Acquisition System on a LEISS Micro-
scope Multicolor Image. Overlays were done using the same system.PCR Screening and Southern Blot Analysis
For bromodeoxyuridine labeling, pregnant mice were injected in-Pools of six individual G418R and GANCR ES cell clones were tested
traperitoneally twice with BrdU (75 mg/g of body weight) on E15 (9for homologous recombination by PCR. The 59 amplimer (59-CATCA
a.m. and9 p.m.)and sacrificed on E17.5. The embryos weremountedGAAGCTGACTCTAGAGG-39) contained the XbaI cleavage site
in OCT before freezing in isopentane cooled in liquid nitrogen. Serial(underlined) and the last 14 bp corresponding to the polyadenylation
frozen 16 mm sections were taken. Sections were fixed as above.site of the PGK1-neo cassette. The 39 amplimer (59-GAAATAGTCAT
To hydrolyze the double-strand DNA for BrdUstaining, we incubatedGACGTCATCAGC-39) corresponded to genomic sequence located
the sections for 1 hr in 2 M HCl, then neutralized with 0.1 M Borax7 bp downstream of the 39 end of the short arm of the targeting
and rinsed in TBST buffer. Anti-bromodeoxyuridine FITC–conjugatevector. For Southern analysis of genomic DNA, ES cells were grown
(monoclonal 102-693, Boehringer Mannheim) and rhodamin-conju-to confluency in 6 cm dishes, and the DNA was extracted following
gated goat anti-rabbit were used to double-label nuclei and thestandard procedures. DNA (20 mg) was digested with NdeI or ApaI,
basal lamina.electrophoresed on a 0.6% agarose gel, blotted, and hybridized
with a 32P-labeled 1.2 kb EcoRI–SapI DNA fragment derived from
the phage genomic sequence located immediately upstream of the Whole-Mount In Situ Hybridization
59 end of the targeting vector. Expression of the met gene was analyzed on E10 mouse embryos
using the 550 bp HindIII–SacI cDNA probe described above in “Tar-
Genotyping geting Vector.” The probe used to analyze the expression of the
Genotypes were identified by PCR analysis on DNA isolated from MyoD gene was a 1.8 kb fragment described in Davis et al. (1987).
embryonal sacs of E12.5–E18.5 embryos and from tails at birth (P0). Mouse embryos were collectedand treated as describedby Haramis
et al. (1995). For whole-mount hybridization, embryos were rehy-
drated through the methanol series and washed twice in PBT (phos-Northern Blot Analysis
phate-buffered saline and 0.1% Tween-20). Digestion with 10 mg/Total RNA was prepared from adult mouse liver by acid guanidin-
ml of proteinase K was carried out for 30 min (E10 embryos) or 45ium thiocyanate-phenol-chlorophorm extraction (Chomczynski and
min (E11.5 embryos) and was followed by washingin glycine solutionSacchi, 1987). RNA was separated by electrophoresis in agarose–
(2 mg/ml). Digested embryos were refixed in glutaraldehyde–formaldehyde gels, blotted into a nitrocellulose filter, and hybridized
paraformaldehyde (0.2%–4%) for 20 min, washed twice with PBT,according to the methods described in Sambrook et al. (1989). The
and transferred to the following mix (50% formamide, 5 3 SSC [pHprobe was a 550 bp HindIII–SacI cDNA fragment, corresponding to
4.5], 2% blocking powder, 0.5 g/ml CHAPS, 50 mg/ml yeast RNA,position 2199–2749 in the mouse cDNA sequence (Chan et al., 1988).
500 mM EDTA) for prehybridization at 708C for at least 3 hr. Synthesis
of anti-sense digoxigenin-labeled RNA probes was performed usingWestern Immunoblotting
a DIG RNA Labeling Kit (Boehringer Mannheim), according to in-Western blot analysis of Met and Grb2 protein was performed as
structions of the manufacturer. The MyoD RNA probe was alkali-previously described (Ponzetto et al., 1994). Briefly, E15.5 embryos
treated to obtain fragments of approximately 200 bp. Hybridizationor tissues/cells were homogenized in lysis buffer (0.3 g/ml), and the
was performedat 708C overnight in the same buffer as prehybridiza-resulting extracts were clarified by centrifugation. The Met receptor
tion, containing 1 mg/ml of digoxigenin-labeled RNA probe. Follow-was immunoprecipitated with an anti-Met monoclonal antibody
ing hybridization, embryos were washed with 75%, 50%, and 25%raised against the 19 carboxy-terminal amino acids of the human
hybridization buffer in 2 3 SSC (pH 4.5) at 708C, followed by twoMet protein (provided by M.Prat) or with an antiserum against mouse
washes in 2 3 SSC (pH 4.5), 0.1% CHAPS. Embryos hybridized withMet protein, which has a very low affinity for the human Met protein
the MyoD probe were treated with 20 mg/ml of RNAse A in 2 3 SSC(m-met SP260, Santa Cruz Biotechnology). Grb2 was immunopre-
(pH 4.5), 0.1% CHAPS at 378C for 1 hr. Embryos hybridized with thecipitated and blotted with an anti-Grb2 monoclonal antibody
met probe were not treated with RNAse A. Embryos were then(G16720, Transduction Laboratories). Immunoprecipitates were
washed twice with 100 mM maleic acid, 150 mM NaCl (pH 7.5) atseparated by SDS–polyacrylamide gel electrophoresis (8% for Met,
room temperature for 10 min and twice at 708C for 30 min. After12% for Grb2), blotted, and incubated with the appropriate antibod-
three washes in PBT, they were incubated overnight at 48C withies. Specific binding was detected by the enhanced chemilumines-
sheep polyclonal alkaline phosphatase-conjugated anti-digoxigenincence system (Amersham).
antibody (Boehringer Mannheim) preadsorbed with mouse embryo
powder. The next day, embryos were washed five times with PBTHistological Analysis
and 0.1% bovine serum albumin, then twice with PBT and finallyPostimplantation embryos wererecovered at various times of gesta-
three times with NTMT (100 mM Tris–HCl [pH 9.5], 100 mM NaCl,tion. The morning the vaginal plug was detected was considered as
50 mM MgCl2, 0.1% Tween-20). The phosphatase reaction was per-day 0.5 postcoitum. Embryos andP0 mice were rinsed in phosphate-
formed in the presence of BM-Purple (Boehringer Mannheim) atbuffered saline (PBS) and mounted in OCT (Miles) before freezing
room temperature. The reaction was stopped with PBT. Embryosin isopentane cooled in liquid nitrogen, and serial frozen 16 mm
were cleared in glycerol/PBT solution and photographed with asections were taken, thaw-mounted onto gelatin-coated glass
Zeiss SR stereomicroscope.slides, and allowed to air-dry. Sections were fixed in 4% paraformal-
dehyde in PBand stained with hematoxylin–eosin. To reveal filamen-
tous actin, we rinsed fixed sections with PBS and with PBS supple- In Situ Hybridization
mented with 0.2% Triton X-100 for 5 min before incubating for 30 In situ hybridization was carried out as described in Hogan et al.
min in 5 mg/ml of TRITC–phalloidin in PBS. After staining, sections (1994), with minor modifications. The appropriate probe (30 ml) in
were rinsed in PBS and mounted with Moviol. Sections were ana- the hybridization mix was added to each slide. Hybridization was
lyzed and photographed under fluorescence optics. carried out overnight at 558C. The slides were then washed under
stringent conditions (at 658C in 2 3 SSC and 50% formamide) and
treated with RNAase to remove unhybridized and nonspecificallyImmunohistochemistry and Bromodeoxyuridine Labeling
For immunofluorescence with anti-myosin and anti-laminin antibod- bound probe. Autoradiography was performed with a Kodak NTB/2
emulsion. Exposure times were between 2 and 3 weeks. After devel-ies, 14 mm of frozen section were fixed in 4% paraformaldehyde in
PB for 5 min and rinsed in TBST solution (100 mM Tris, 0.84% NaCl, oping, sections were stained in 0.02% toluidine blue and mounted
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in DePex (Serva). Sections were examined and photographed using Park, M. (1995). Efficient cell transformation by the Tpr-Met onco-
protein is dependent upon tyrosine 489 in the carboxy-terminus.a Zeiss SV11 microscope with both dark and bright field illumination.
Oncogene 10, 237–249.
Fixman, E.D., Fournier, T.M., Kamikura, D.M., Naujokas, M.A., andCell Cultures
Park, M. (1996). Pathways downstream of Shc and Grb2 are requiredMyoblasts were cultured from limbs of E16.5 mouse embryos as
for cell transformation by the Tpr-Met oncoprotein. J. Biol. Chem.described in Rando and Blau (1994). The limbs were isolated from
271, 13116–13122.the embryo and, after removal of the skin and bones, were digested
Gherardi, E., and Stoker, M. (1991). Hepatocyte growth factor-scat-with 2.4 U/ml of dispase II (Boehringer Mannheim), 0.25% collagen-
ter factor: mitogen, motogen, and met. Cancer Cells 3, 227–232.ase B (Boehringer Mannheim), 150 ng/ml of DNAse I (Boehringer
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